Skip to content

USG guided intervention of pudendal nerve in bladder dysfunction in spinal injury patients.

Effectiveness of USG guided bilateral pudendal nerve block in case of detrusor sphincter dyssynergia due to traumatic spinal cord injury. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088022
Enrollment
100
Registered
2025-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N31- Neuromuscular dysfunction of bladder, not elsewhere classified Health Condition 2: N318- Other neuromuscular dysfunction ofbladder

Interventions

Intervention1: Bilateral Pudendal Nerve Block as add on therapy with conservative management: In this study, patients with detrusor sphincter dyssynergia secondary to spinal cord injury will be enlist

Sponsors

IPGMER AND SSKM HOSPITAL KOLKATA WEST BENGAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)UDS confirmed detrusor sphincter dyssynergia secondary to traumatic spinal cord injury 2)Traumatic Spinal Cord Injury(SCI) of more than 3 months duration 3)SCI in AIS stage A,B 4)Patient able to and willing to perform CIC. 5)Patient mentally sound enough to communicate and participate in the study and can understand the parameters well.

Exclusion criteria

Exclusion criteria: 1)Urinary Tract Infection 2)Painful bladder syndrome or Interstitial Cystitis 3)Non-traumatic SCI 4)SCI in AIS stage C,D 5)Patient with indwelling catheter 6)Bladder stone 7)BHP or Prostatic cancer 8)Bleeding diathesis 9)Neuromuscular transmission disorder (e.g. myasthenia gravis, Eaton-lambert syndrome) 10)The presence of an unstable medical condition or a known uncontrolled systemic disease.

Design outcomes

Primary

MeasureTime frame
USG guided bilateral pudendal nerve block has a very good outcome as an add on treatment with conservative therapy in terms of improvement of maximum cystometric capacity, post void residual urine, Frequency of Incontinence/ retention of urine.Timepoint: At baseline, at 6 weeks and 3 months

Secondary

MeasureTime frame
patient may have decreased Post void residual urine at 3 months but maximum cystometric capacity may not increased up to 3 monthsTimepoint: At base line, at 6 weeks & 3 months.

Countries

India

Contacts

Public ContactDR RAJESH PRAMANIK

IPGMER AND SSKM HOSPITAL

rpramanik2000@yahoo.com9432594882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026